Petronila Penela

3PUBLICATIONS
36CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 28, 2024
GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner.

Verónica Rivas, Teresa González-Muñoz, Ángela Albitre

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Dec 23, 2022
Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers.

Anaïs Jiménez-Reinoso, Néstor Tirado, Alba Martinez-Moreno

Pageof 1